CLS studies demonstrate safe treatment with the TRANBERG system
Clinical Laserthermia Systems (CLS) (publ), which develops and markets Interstitial Laser Thermo Therapy imILT, a polyclinical, heat-induced cancer immunotherapy, has completed the first phase of a clinical study to evaluate the safety of the TRANBERG system with respect to imILT treatment. A total of eight treatments have been included in this first internal Post-Market Clinical Follow-up report, from which it can be concluded that the imILT treatment is safe, provided that the procedures are performed in accordance with the treatment instructions. No serious side effects that can be